| Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018 | 1753 | 2018 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1154 | 2019 |
| EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update CPG Panel, A Berzigotti, E Tsochatzis, J Boursier, L Castera, N Cazzagon, ... Journal of hepatology 75 (3), 659-689, 2021 | 847 | 2021 |
| Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis E Villa, C Cammà, M Marietta, M Luongo, R Critelli, S Colopi, C Tata, ... Gastroenterology 143 (5), 1253-1260. e4, 2012 | 844 | 2012 |
| Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis S McPherson, T Hardy, JF Dufour, S Petta, M Romero-Gomez, M Allison, ... Official journal of the American College of Gastroenterology| ACG 112 (5 …, 2017 | 745 | 2017 |
| The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 672 | 2016 |
| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 595 | 2015 |
| Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C S Petta, C Cammà, C Scazzone, C Tripodo, V Di Marco, A Bono, D Cabibi, ... Hepatology 51 (4), 1158-1167, 2010 | 572 | 2010 |
| Non-alcoholic fatty liver disease pathogenesis: the present and the future S Petta, C Muratore, A Craxi Digestive and Liver Disease 41 (9), 615-625, 2009 | 476 | 2009 |
| Statin use and non-alcoholic steatohepatitis in at risk individuals P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ... Journal of hepatology 63 (3), 705-712, 2015 | 459 | 2015 |
| Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation ZM Younossi, G Marchesini, H Pinto-Cortez, S Petta Transplantation 103 (1), 22-27, 2019 | 446 | 2019 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 410 | 2020 |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 368 | 2022 |
| Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinè, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 343 | 2018 |
| Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice G Marchesini, S Petta, R Dalle Grave Hepatology 63 (6), 2032-2043, 2016 | 342 | 2016 |
| Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver P Dongiovanni, S Stender, A Pietrelli, RM Mancina, A Cespiati, S Petta, ... Journal of internal medicine 283 (4), 356-370, 2018 | 335 | 2018 |
| AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 323 | 2017 |
| Lean NAFLD: a distinct entity shaped by differential metabolic adaptation F Chen, S Esmaili, GB Rogers, E Bugianesi, S Petta, G Marchesini, ... Hepatology 71 (4), 1213-1227, 2020 | 307 | 2020 |
| Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies S Petta, M Maida, FS Macaluso, M Barbara, A Licata, A Craxì, C Cammà Gastroenterology 150 (1), 145-155. e4, 2016 | 294 | 2016 |
| Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science translational medicine 12 (572), eaba4448, 2020 | 291 | 2020 |
